Skip to content
  1. Home/
  2. Media Center/
  3. Press releases /
  4. Medical technologies

Medical technologies

New Data Show On-Demand, Mealtime Insulin Delivery System Enabled More than 50 Percent of Patients to Report Improved Dose Compliance

Innovative, In-Development Patch Allows Simple and Discreet Dosing and Greater Patient Satisfaction

DePuy Synthes Companies Announces Acquisition Of Biomedical Enterprises, Inc., A Leader In Small Bone Fixation

Acquisition of Nitinol Implant Company Strengthens Johnson & Johnson Medical Devices Position in Elective Extremity Surgery, the Fastest Growing Segment in Orthopaedics

Ethicon Announces Agreement To Acquire NeuWave Medical, Inc.

NeuWave Medical Technology Offers Minimally Invasive Intervention Option for Patients with Soft Tissue Lesions

DePuy Synthes Companies Announces New Strategic Alliance with Experts in Bundled Payments

Part of DePuy Synthes Companies’ Broader Effort to ‘Go Beyond the Implant’

New Onetouch Verio Flex™ Blood Glucose Monitoring System with ColorSure™ Technology Takes the Guesswork Out of Blood Sugar Test Results

-- 9 out of 10 People With Diabetes Agree The System’s Simple Color Range Indicator Helps Them Easily Interpret Their Blood Sugar Readings --

FDA Approves Animas® Vibe® Insulin Pump and Continuous Glucose Monitoring System For Use in Children

Insulin Pump System Offers Children Ages Two and Older an Integrated Solution for Diabetes Management

Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.

The addition of the Coherex WaveCrest® Left Atrial Appendage Occlusion System to the company’s portfolio expands range of treatment options for patients with atrial fibrillatio

OneTouch Reveal® App for Diabetes Management Adds Support for HealthKit

1.3 Million Blood Glucose Monitoring Testing Strips to be Donated to International Diabetes Federation’s Life for a Child in Honor of World Diabetes Day

Johnson & Johnson Vison Care, Inc. Launches New Lens With A Tear-Infused Design

ACUVUE OASYS® Brand Contact Lenses 1-Day with HydraLuxe™ Technology help support the natural tear film and was preferred overall to the competition in a head-to-head study1